Research Information
Semax
Nootropic · Synthetic ACTH-fragment analogue
Short research overview
Semax is classified as a synthetic analogue derived from an ACTH fragment. This origin distinguishes it from Selank’s tuftsin-analogue classification even though both entries sit within the broader nootropic and neuropeptide research catalogue.
View the Semax product page·Selank vs SemaxHow it is being studied
Existing information links Semax with neuropeptide signalling and neurotrophin-expression pathways. Cellular-stress research is also listed as a relevant model, without presenting these topics as proof of a resolved mechanism.
Areas of Research
- ACTH-fragment analogue characterisation
- Semax neurotrophin-expression models
- Neuropeptide responses in cellular-stress research
Current Research Status
Research reference only. This entry does not represent an approved therapeutic use or medical recommendation.
Available Strength
10mg
Scientific References
Semax literature index
PubMed · National Library of Medicine
For Research Purposes Only
This information is provided as a scientific reference and does not include medical, dosing, administration or human-use guidance.